New TIDI Glove Products Added to Novation Contract
TIDI Products LLC, a manufacturer of single-use infection prevention products for medical and dental markets, has added three new gloves to its Novation LLC contract. The gloves include the 18 mil P2® HiRisk Latex Exam Gloves, 15 mil P2® SafetyPlus Latex Exam Gloves, and the 8 mil P2® Nitrile Exam Gloves.
The three gloves are use in high risk applications such as sterile processing/decontamination and chemotherapy drug compounding and administration. The 18 mil and 8 mil gloves are chemotherapy tested per the ASTM Standard D6978-05.
The existing contract, which began Nov. 1, 2010, runs through Oct. 31, 20111. The glove addition to the contract will complete Novations current offer to members for nitrile, vinyl and latex gloves.
CDC HICPAC Considers New Airborne Pathogen Guidelines Amid Growing Concerns
November 18th 2024The CDC HICPAC discussed updates to airborne pathogen guidelines, emphasizing the need for masks in health care. Despite risks, the committee resisted universal masking, highlighting other mitigation strategies
Breaking the Cycle: Long COVID's Impact and the Urgent Need for Preventative Measures
November 15th 2024Masking, clean air, and vaccinations are essential in combating COVID-19 and preventing long-term impacts, as evidence mounts of long COVID's significant economic, cognitive, and behavioral effects.
The Critical Role of Rapid Diagnostics in Antibiotic Stewardship
November 6th 2024Rapid diagnostics enhance patient outcomes by enabling prompt, targeted treatments, reducing inappropriate antibiotic use, and combating antimicrobial resistance through informed clinical decisions and stewardship programs.
